Akero Therapeutics Inc. (AKRO)
undefined
undefined%
At close: undefined
27.11
-1.92%
Pre-market Jan 07, 2025, 06:44 AM EST

Ratios (Annual)

Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17
PE Ratio -8.09 -19.62 -7.31 -10.25 -7.65 -4.76 -114.62
PS Ratio n/a n/a n/a n/a n/a n/a n/a
PB Ratio 2.29 6.54 4.36 3.14 2.60 -7.79 -114.62
P/FCF Ratio -8.44 -23.09 -9.24 -11.44 -9.39 -40.4 -119.38
P/OCF Ratio -8.44 -23.09 -9.24 -11.46 -9.39 -84.07 -119.38
OCF/S Ratio n/a n/a n/a n/a n/a n/a n/a
Debt / Equity Ratio 0.05 0.03 0.01 0.01 n/a n/a n/a
Quick Ratio 29.27 18.61 7.70 20.70 14.73 32.93 2.87
Current Ratio 29.27 18.61 7.70 20.70 14.73 32.93 2.87
Asset Turnover n/a n/a n/a n/a n/a n/a n/a
Interest Coverage -55.78 -155.83 n/a n/a n/a n/a n/a
Return on Equity (ROE) -0.28 -0.33 -0.6 -0.31 -0.34 1.64 1.00
Return on Assets (ROA) -0.26 -0.31 -0.52 -0.29 -0.32 -1.06 -6.94
Return on Capital (ROIC) -0.31 -0.34 -0.59 -0.31 -0.35 -0.18 -10.47
Dividend Yield n/a n/a n/a n/a n/a n/a n/a
Payout Ratio n/a n/a n/a n/a n/a n/a n/a
Gross Profit Margin n/a n/a n/a n/a n/a n/a n/a
Net Profit Margin n/a n/a n/a n/a n/a n/a n/a
Pretax Profit Margin n/a n/a n/a n/a n/a n/a n/a
Operating Profit Margin n/a n/a n/a n/a n/a n/a n/a
FCF Margin n/a n/a n/a n/a n/a n/a n/a
EBITDA Margin n/a n/a n/a n/a n/a n/a n/a